Online citations, reference lists, and bibliographies.

Body Mass Index In Relation To Serum Prostate‐specific Antigen Levels And Prostate Cancer Risk

S. Bonn, A. Sjölander, Annika Tillander, F. Wiklund, H. Grönberg, K. Bälter
Published 2016 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
High Body mass index (BMI) has been directly associated with risk of aggressive or fatal prostate cancer. One possible explanation may be an effect of BMI on serum levels of prostate‐specific antigen (PSA). To study the association between BMI and serum PSA as well as prostate cancer risk, a large cohort of men without prostate cancer at baseline was followed prospectively for prostate cancer diagnoses until 2015. Serum PSA and BMI were assessed among 15,827 men at baseline in 2010–2012. During follow‐up, 735 men were diagnosed with prostate cancer with 282 (38.4%) classified as high‐grade cancers. Multivariable linear regression models and natural cubic linear regression splines were fitted for analyses of BMI and log‐PSA. For risk analysis, Cox proportional hazards regression models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) and natural cubic Cox regression splines producing standardized cancer‐free probabilities were fitted. Results showed that baseline Serum PSA decreased by 1.6% (95% CI: −2.1 to −1.1) with every one unit increase in BMI. Statistically significant decreases of 3.7, 11.7 and 32.3% were seen for increasing BMI‐categories of 25 < 30, 30 < 35 and ≥35 kg/m2, respectively, compared to the reference (18.5 < 25 kg/m2). No statistically significant associations were seen between BMI and prostate cancer risk although results were indicative of a positive association to incidence rates of high‐grade disease and an inverse association to incidence of low‐grade disease. However, findings regarding risk are limited by the short follow‐up time. In conclusion, BMI was inversely associated to PSA‐levels. BMI should be taken into consideration when referring men to a prostate biopsy based on serum PSA‐levels.
This paper references
10.1159/000406427
Implications for population studies of the age trend in blood pressure.
Michael Marmot (1982)
10.1016/j.urology.2007.11.049
Body composition and serum prostate-specific antigen: review and findings from Flint Men's Health Study.
J. Beebe-Dimmer (2008)
10.1016/j.eururo.2012.02.054
International variation in prostate cancer incidence and mortality rates.
Melissa M. Center (2012)
10.1016/S0022-5347(01)68793-7
Observed effect of age and body mass index on total and complexed PSA: analysis from a National Screening Program.
P. Walsh (2005)
10.1080/02841860802247664
The completeness of the Swedish Cancer Register – a sample survey for year 1998
L. Barlow (2009)
10.1016/S1078-1439(03)00171-6
Relationship of body mass index and prostate specific antigen in a population-based study.
I. Thompson (2004)
10.1016/j.eururo.2012.10.001
Prostate-specific antigen (PSA) testing is prevalent and increasing in Stockholm County, Sweden, Despite no recommendations for PSA screening: results from a population-based study, 2003-2011.
Tobias Nordström (2013)
R Development Core Team (2010): R: A language and environment for statistical computing
P. Dalgaard (2010)
10.1093/annonc/mdr603
Body mass index and incidence of localized and advanced prostate cancer--a dose-response meta-analysis of prospective studies.
A. Discacciati (2012)
10.1038/OBY.2007.536
The validity of obesity based on self-reported weight and height: Implications for population studies.
M. Nyholm (2007)
10.1111/j.1464-410X.2011.10227.x
Obesity and prostate enlargement in men with localized prostate cancer
R. Kopp (2011)
Modern Epidemiology 3rd edition
K. Rothman (2008)
10.1002/pros.21380
The effect of demographic and clinical factors on the relationship between BMI and PSA levels.
J. Wright (2011)
10.1002/ijc.29210
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
J. Ferlay (2015)
10.1007/978-1-4612-6333-3
A Practical Guide to Splines
C. Boor (1978)
10.1001/JAMA.298.19.2275
Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer.
L. Banez (2007)
10.1158/1055-9965.EPI-08-0938
Serum Prostate-Specific Antigen Hemodilution Among Obese Men Undergoing Screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
R. Grubb (2009)
Obesity, serum prostate specific antigen and prostate C an ce r E pi de m io lo gy 56 BMI in relation to serum PSA levels and prostate cancer risk
SJ Freedland (2016)
10.1016/j.jsbmb.2004.10.002
The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer
E. Platz (2004)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN
J Ferlay (2012)
10.1002/pros.20704
Obesity and screening PSA levels among men undergoing an annual physical exam.
A. Rundle (2008)
10.1093/ije/dys068
Cohort Profile: the National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0.
M. van Hemelrijck (2013)
10.1002/cncr.20856
The association of body mass index and prostate‐specific antigen in a population‐based study
J. Baillargeon (2005)
10.1111/j.1464-410X.2012.11731.x
Quantitative measurement of the androgen receptor in prepuces of boys with and without hypospadias
R. Pichler (2013)
10.1093/AJCN/68.4.899
Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults.
F. Pi-Sunyer (1998)
10.1016/S0022-5347(05)00162-X
Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection.
S. Freedland (2006)
10.1016/j.eururo.2013.07.005
A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng/ml.
Tobias Nordström (2014)
10.1111/j.1464-410X.2012.11766.x
Does obesity affect the accuracy of prostate‐specific antigen (PSA) for predicting prostate cancer among men undergoing prostate biopsy
J. Oh (2013)
10.1016/j.eururo.2014.08.010
Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer.
Tobias Nordström (2015)
10.1016/j.eururo.2012.11.013
Obesity and prostate cancer: weighing the evidence.
E. Allott (2013)
10.1038/sj.ijo.0801742
Relating body mass index to figural stimuli: population-based normative data for Caucasians
CM Bulik (2001)
10.1002/cncr.21603
Associations of demographic and lifestyle characteristics with prostate‐specific antigen (PSA) concentration and rate of PSA increase
A. Kristal (2006)
10.1016/J.UROLOGY.2005.04.040
Influence of anthropometric measurements, age, and prostate volume on prostate-specific antigen levels in men with a low risk of prostate cancer.
A. Ochiai (2005)



This paper is referenced by
10.1080/13685538.2017.1379491
The influence of nutritional factors on prostate cancer incidence and aggressiveness
M. Pascual-Geler (2018)
10.1038/bjc.2017.312
Prospective investigation of risk factors for prostate cancer in the UK Biobank cohort study
A. Perez-Cornago (2017)
10.1007/S00542-018-4036-6
A non-invasive cancer gene detection technique using FLANN based adaptive filter
Saikat Singha Roy (2018)
OTT_A_197507 3313..3319
L. Zhou (2019)
10.2147/OTT.S197507
Altered circulating levels of adipokine omentin-1 in patients with prostate cancer
Lin Zhou (2019)
10.35371/aoem.2019.31.e19
Night shiftwork and prostate-specific antigen level in a tire manufacturing factory
Seunghyeon Cho (2019)
10.9734/JCTI/2019/V9I330107
Body Mass Index and Age Correlation with Prostate-specific Antigen Density as Prostate Cancer Risk Indicators in a Screened Male University Population in Nigeria: A Pilot Study
Eyam Sunday Eyam (2019)
10.1530/ERC-17-0438
The inverse relationship between prostate specific antigen (PSA) and obesity.
Adel T. Aref (2018)
10.1101/671123
A Comprehensive Genome-wide and Phenome-wide Examination of BMI and Obesity in a Northern Nevadan Cohort
Karen Schlauch (2019)
10.1038/s41416-020-1012-6
Association of obesity status and metabolic syndrome with site-specific cancers: a population-based cohort study
Z. X. Cao (2020)
10.1016/j.puhe.2020.01.003
All-cancer incidence in Tehranian adults: more than a decade of follow-up-results from the Tehran Lipid and Glucose Study.
Farzad Hadaegh (2020)
10.1016/j.mcna.2017.06.004
Diet, Physical Activity, and Body Weight in Cancer Survivorship.
Karishma Mehra (2017)
10.1534/g3.119.400910
A Comprehensive Genome-Wide and Phenome-Wide Examination of BMI and Obesity in a Northern Nevadan Cohort
Karen Schlauch (2019)
10.1002/cam4.1747
BMI trajectories and risk of overall and grade‐specific prostate cancer: An observational cohort study among men seen for prostatic conditions
K. Wang (2018)
Circulating levels of adiponectin and leptin in patients with prostate cancer
Li-Gang Zhang (2018)
10.1097/MOU.0000000000000424
Obesity and prostate cancer
M. Bandini (2017)
10.1007/s10552-020-01291-3
Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen
Sean Harrison (2020)
Semantic Scholar Logo Some data provided by SemanticScholar